How to Source Lamivudine Stavudine & Nevirapine for Pharmaceutical Formulation
Lamivudine Stavudine & Nevirapine (Tablet, Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg) is classified under Anti Viral. It is therapeutically aligned with reference brands such as Triomune®(Global). This guide highlights key sourcing factors buyers should consider when procuring high-quality Lamivudine Stavudine & Nevirapine for formulation, R&D, or bulk manufacturing.
Product Overview:
Lamivudine, Stavudine & Nevirapine Tablets, often used in first-line HIV treatment, are available in 150/30/200 mg strength. Trusted brands like Triomune® offer affordable and effective ART. Via PharmaB2B, bulk procurement from WHO-GMP suppliers supports government tenders and HIV care programs in developing regions.
Lamivudine, Stavudine & Nevirapine Tablets are a fixed-dose antiretroviral combination widely us...
Lamivudine Stavudine & Nevirapine API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Lamivudine Stavudine & Nevirapine must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Lamivudine Stavudine & Nevirapine is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Lamivudine Stavudine & Nevirapine is more than procurement—it’s a strategic partnership. With its tablet form and Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Lamivudine Stavudine & Nevirapine.
Request a Quote
Frequently Asked Questions For Sourcing of Lamivudine Stavudine & Nevirapine
What is the typical lead time for Lamivudine Stavudine & Nevirapine?
Lead times range from 4–6 weeks depending on supplier and region.
Is Lamivudine Stavudine & Nevirapine available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Lamivudine Stavudine & Nevirapine require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Lamivudine Stavudine & Nevirapine?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Lamivudine Stavudine & Nevirapine?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Lamivudine Stavudine & Nevirapine?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Lamivudine Stavudine & Nevirapine suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Lamivudine Stavudine & Nevirapine be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.